Efficacy of grafted immortalized dopamine neurons in an animal model of Parkinsonism: A review

Molecular Genetics and Metabolism

Volumn 65, Issue 1, 1998, Pages 1-9

  Prasad, Kedar N ^a   Clarkson, Edward D ^a   La Rosa, Francisco G ^a   Edwards Prasad, Judith ^a   Freed, Curt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

6 hydroxydopamine lesion; Dopamine neurons; Immortalization; Parkinson disease; SV40 large T antigen gene; Transplantation

Indexed keywords

OXIDOPAMINE; VIRUS LARGE T ANTIGEN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL POPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE INSERTION; GRAFT REJECTION; IMMUNOGENICITY; MESENCEPHALON; NERVE GRAFT; NEUROFILAMENT; NONHUMAN; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; RAT; SHORT SURVEY;

ANIMALIA; SV40 VIRUS;

EID: 0031767323     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1998.2726     Document Type: Article

References (66)

1. Barbeau A. The pathogenesis of Parkinson's disease: A new hypothesis. Can Med Assoc J. 87:1962;802-807.
2. Cotzias G C, Van Woert M H. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 276:1967;374-379.
3. Sax D S, Tarsy D. Side-effects ofL. N Engl J Med. 285:1971;1033.
4. Pentland B, Matthews D, Mawdsley C. Parkinson's disease: Long-term results of levodopa therapy. Scott Med J. 27:1982;284-287.
5. Kaye J A, Feldman R G. The role ofL. Clin Neuropharmacol. 9:1986;1-13.
6. Björklund A, Steveni U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
7. Perlow M J, Freed W J, Hoffer B J, Seiger A, Olson L, Wyatt R J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 204:1979;643-647.
8. Bakay R AE, Barrow D L, Fiandaca M S, Iuvone P M, Schiff A, Collins D C. Biochemical and behavioral correction of MPTP-like syndrome by fetal cell transplantation. Ann N Y Acad Sci. 495:1987;623-640.
9. Björklund A, Stenevi U. Intracerebral neural implants: Neuronal replacement and reconstruction of damaged circuitries. Annu Rev Neurosci. 7:1984;279-308.
10. Bohn M C, Cupit L, Marciano F, Gash D M. Adrenal medulla graft enhanced recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
11. Dunnett S, Annett L E. Nigral transplants in primate model of parkinsonism. Intracerebral Transplantation in Movement Disorders, Vol. 4, Restorative Neurology and Neuroscience. 1991;Elsevier, Amsterdam. p. 27-51.
12. Dunnett S B, Hernandez T, Summerfield A, Jones G H. Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp Brain Res. 71:1988;411-424.
13. Freed W J, Polterak N, Becker J B. Intracerebral adrenal medulla grafts: A review. Exp Neurol. 110:1990;139-166.
14. Gash D M, Collier T J, Sladek J R Jr. Neural transplantation: A review of recent developments and potential application to aged brain. Neurobiol Aging. 6:1985;131-150.
15. Kordower J H, Fiandaca M S, Notter M FD, Anthony A. Scientific basis for dopaminergic brain grafting. Koller WC Paulson G. Therapy of Parkinson's Disease. 1990;443-472 Dekker, New York.
16. Brundin P, Isacson O, Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:1985;251-259.
17. Tandon P N, Gopinath G, Mahapatra A K, Banerjee R, Shetty A K. Neural transplantation in mammals: Our experience. Proc Ind Acad Sci. B56:1990;551-558.
18. Widner H, Brundin P. Immunological aspects of grafting in the mammalian central nervous system: A review and speculative synthesis. Brain Res Rev. 13:1988;287-324.
19. Yurek D, Sladek J R Jr. Dopamine cell replacement: Parkinson's disease. Annu Rev Neurosci. 13:1989;415-440.
20. Allen G S, Burns R S, Tulpan N B, Parker R A. Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease: Intial clinical results in 18 patients. Arch Neurol. 46:1989;487-491.
21. Freed C R, Breeze R E, Rosenberg N L, Schneck S A, Wells T H, Barrett J N, Grafton S T, Huang S C, Eidelberg D, Rohenberg D A. Transplantation of human fetal dopamine cells for Parkinson's disease. Arch Neurol. 47:1990;505-512.
22. Freed C R, Breeze R E, Rosenberg N L, Schneck S A, Kriek E, Qi J X, Lone T, Zhang Y B, Synder J A, Wells T H. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplant for Parkinson's disease. N Engl J Med. 327:1992;1549-1555.
23. Goetz C G, Olanow C W, Koller W C, Penn R D, Cahill D, Morantz R, Stebbins G, Tanner C M, Klawans H L, Shannon K M. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 320:1989;337-341.
24. Henderson B T, Clough C G, Hughes R C, Hitchcock E R, Kenny B G. Implantation of human ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol. 48:1991;822-827.
25. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leenders K L, Rothwell J C. Human fetal dopamine neurons grafted into striatum in two patients with severe Parkinson's disease. Arch Neurol. 46:1989;615-631.
26. Lindvall O, Backlund E O, Farde L, Sadvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Ann Neurol. 22:1987;457-468.
27. Lindvall, O, Brundin, P, Widner, H, Rehncrona, S, Gustavii, B, Frackowiak, R, Leenders, K, L, Sawle, G, Rothwell, J, C, Marsden, C, D, Björklund, A, Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease, Science, 247, 574, 577.
28. Lindvall O, Widner H, Rehncrona S, Brundin P, Odin P, Gustavii B, Frackowiak R, Leenders K L, Sawle G, Rothwell J C. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurological observations in two patients with putaminal implants. Ann Neurol. 31:1992;155-165.
29. Madrazo I, Leon V, Torres C, Aguilera M C, Varela G, Alvarez F, Fraga A, Drucker-Colin R, Ostrosky F, Skurovich M. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N Engl J Med. 318:1988;51.
30. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J, Torres C, Becerril J J. Open microsurgical autograft of adrenal medulla to the caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med. 316:1987;831-834.
31. Madrazo I, Franco-Bourland R, Ostrosky-Solis F, Aguilera M, Cuevas C, Zamorano C, Morelos A, Magallion E, Guizar-Sahagun G. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinson's subjects. Arch Neurol. 48:1990;1281-1285.
32. 18L. Ann Neurol. 31:1992;166-173.
33. La Rosa F G, Talmage D W. Major histocompatability complex antigen expression on parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection. Transplantation. 49:1990;605-609.
34. Prasad K N, Mandal B, Waymire J C, Lees G J, Vernadakis A, Weiner N. Basal levels of neurotransmitter synthesizing enzymes and effect of cyclic AMP agents on the morphological differentiation of isolated neuroblastoma clones. Nature New Biol. 241:1973;117-119.
35. Augusti-Tocco G, Sato G. Establishment of functional clonal line of neurons from mouse neuroblastoma. Proc Natl Acad Sci USA. 64:1969;311-315.
36. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Patrick J, Steinbach J H, Culp W, Brandt B L. Clonal cell lines from the rat central nervous system. Nature. 249:1974;224-227.
37. Tumilowicz J J, Nichols W W, Cholon J J, Green A E. Definition of a continuous cell line derived from neuroblastoma. Cancer Res. 30:1970;2110-2118.
38. Beidler, J, L, Helson, L, Spengler, B, A, Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous cultures, Cancer Res, 33, 12643, 12652.
39. Winn S R, Tresco P A, Zielinski B, Greene L A, Jaeger C B, Aebischer P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp Neurol. 113:1991;322.
40. Trojanowski J Q, Mantione J R, Lee J H, Seid D P, You T, Inge L J, Lee V M. Neurons derived from a human teratocarinoma cell line establish molecular and structural polarity following transplantation into the rodent brain. Exp Neurol. 122:1993;283-294.
41. Prasad K N, Carvalho E, Kentroti S, Edwards-Prasad J, Freed C R, Vernadakis A. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol. 30A:1994;596-603.
42. Adams F S, La Rosa F G, Kumar S, Edwards-Prasad J, Kentroti S, Vernadakis A, Freed C R, Prasad K N. Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem Res. 21:1996;619-627.
43. Anton R, Kordower J H, Maidment N T, Manaster J S, Kane D J, Rabizadeh S, Schueller S B, Yang J, Rabizadeh S, Edwards R H. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol. 127:1994;207-218.
44. Ryder E F, Snyder E Y, Cepko C L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J Neurobiol. 21:1990;365-375.
45. Freed W J, Vaidya-Patel U, Geller H M. Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain. Exp Brain Res. 63:1986;557-566.
46. Kordower J H, Notter M F, Gash D M. Neuroblastoma cells in neural transplants: A neuroanatomical and behavioral analysis. Brain Res. 417:1987;85-98.
47. Brundin P, Barbin G, Strecker R E, Isacson O, Prochiantz A, Björklund A. Survival and function of dissociated rat dopamine neurones grafted at different development stages or after being culturedin vitro. Dev. Brain Res. 39:1988;233-243.
48. Freeman, T, B, Kordower, J, H, Human cadaver embryonic substantia nigra grafts: Ontogeny, preoperative graft preparation and tissue storage, Intracerebral Transplantation in Movement Disorders, Lindvall, OBjörklund, AWidner, H, Amsterdam, Elsevier, 1991, 163.
49. Redmond D E Jr, Naftolin F, Collier T J, Levanth C, Robbins R J, Sladek C D, Roth R H, Skadek J R Jr. Cryopreservation, culture and transplantation of human fetal mesencephalic tissue into monkeys. Science. 242:1988;768.
50. Lacy P E, Davie J M. Transplantation of pancreatic islets. Annu Rev Immunol. 2:1984;183-198.
51. Gill T J III, Lund R D. Implantation of tissue into the brain: An immunologic perspective. JAMA. 261:1989;2674-2676.
52. Lawrence J M, Morris R J, Wilson D J, Raisman G. Mechanisms of allograft rejection in the rat brain. Neuroscience. 37:1990;431-462.
53. Bakay R AE, Fiandaca M S, Barrow D L, Schiff A, Collins D C. Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. Appl Neurophysiol. 48:1985;358.
54. Fine A, Hunt S P, Oertel W H, Chong P N, Bond A, Waters C, Temlett J A, Annett L, Dunnett S, Jenner P, Marsden C D. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6- terahydropyridine. Prog Brain Res. 78:1988;479.
55. Taylor J R, Elsworth J D, Roth R H, Sladek J R, Collier T J, Redmond D E. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp Brain Res. 85:1991;335.
56. Sladek J R Jr, Collier T J, Haber S N, Deutch A Y, Elsworth J D, Roth R H, Redmond D E. Reversal of parkinsonism by fetal nerve cell transplants in primate brain. Ann N Y Acad Sci. 495:1987;641.
57. Tandon P N, Gopinath G. Clinical use of neural transplants: The unresolved problems. Marwah J Teitelbaum H, Prasad K N. Neural Transplantation: CNS Neuronal Injury and Regeneration. 1994;1-15 CRC Press, Boca Raton.
58. Zawada W M, Zastrow D J, Clarkson E D, Adams F S, Bell K P, Freed C R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.
59. Takayama H, Ray J, Raymon H K, Baird A, Hogg J, Fisher L J, Gage F H. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1:1995;53-58.
60. Prasad K N, Carvalho E, Kentroti S, Edwards-Prasad J, La Rosa F G, Kumar S, Freed C R, Vernadakis A. Production of terminally differentiated neuroblastoma cells in culture. Restor Neurol Neurosci. 7:1994;13-19.
61. Clarkson E D, La Rosa F G, Edwards-Prasad J, Weiland D A, Witta S E, Freed C R, Prasad K N. Improvement of neurological deficits in 6-hydroxydopamine lesioned rats following transplantation with allogeneic SV40 large T-antigen gene-induced immortalized dopamine cells. Proc Natl Acad Sci USA. 95:1998;1265-1270.
62. La Rosa F G, Adams F S, Krause G E, Meyers A D, Edwards-Prasad J, Kumar R, Freed C R, Prasad K N. Inhibition of proliferation and expression of T-antigen in SV40 large T-antigen gene-induced immortalized cells following transplantation. Cancer Lett. 113:1997;55-60.
63. Clarkson E D, La Rosa F G, Edwards-Prasad J, Kumar S, Kumar A, Cole W, Freed C R, Prasad K N. Brain contains inhibiting factors specific to the large T-antigen gene. Cancer Lett. 122:1998;31-36.
64. Richards J B, Sabol K E, Freed C R. Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats. Pharmacol Biochem Behav. 36:1990;217-223.
65. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand. 367:1971;49-68.
66. Freed W J, Hoffer B J, Olson L, Wyatt R J. Transplantation of catechcholamine-containing tissues to restore the functional capacity of the damaged nigrostriatal system. Sladek J J, Gash D M. Neural Transplants: Developmental Function. 1984;373 Plenum, New York.